Nuclear Is the Energy Story of 2026. Here Are 3 Stocks to Own All Year.

The article is constructive on nuclear-related equities, highlighting a potential >50% increase in global nuclear capacity from 2025 to 2050 and strong operating leverage for Cameco, BWX Technologies, and Oklo. Cameco mined 15% of global uranium in 2025, BWX is winning more government and commercial contracts, and Oklo’s first Powerhouse reactors are expected online in Idaho in 2027, with analysts projecting 2027/2028 revenue growth of 338% and 968% for Oklo. Despite elevated valuations, the piece argues these stocks could benefit from a multi-year nuclear boom driven by rising energy demand, AI, and data centers.

Analysis

The real second-order setup is not just higher uranium demand; it is a re-pricing of long-duration nuclear capacity across the supply chain. The best risk-adjusted winner is BWXT because it monetizes scarcity in regulated components, naval work, and fuel-cycle bottlenecks regardless of whether new gigawatt-scale reactors or microreactors win the next round of deployment. That makes it structurally less exposed to spot uranium volatility than CCJ and far less binary than OKLO.

CCJ still has torque, but the market is likely underestimating how much of the upside is already being pulled forward by sentiment rather than fundamentals. Uranium equities usually overshoot on the first leg of a commodity upcycle, then stall if utilities have not locked in long-term contracting; if prices flatten before utility restocking accelerates, CCJ can de-rate even in a bullish macro tape. BWXT’s backlog quality matters more than headline growth because defense and naval budgets can offset a soft patch in commercial nuclear capex.

OKLO is the most interesting contrarian name because it is effectively a call option on licensing, fuel availability, and utility adoption, not a near-term operating business. The market is paying for a 2027+ outcome that still depends on execution across regulatory milestones and HALEU supply, so any delay would hit multiple compression hard. The upside scenario is asymmetric, but the path is long and financing-sensitive, which argues for using options rather than equity if expressing the view.

Consensus is probably underestimating how much incremental nuclear demand will be captured by the enabling layer, not the reactor developers themselves. If AI/data center power demand remains the marginal driver, the winners are the firms that can sell components, fuel handling, and service contracts into a constrained industrial base. That creates a cleaner relative-value trade than owning the broad basket.

Key Decisions for Investors

• Long BWXT vs CCJ over 3-6 months: BWXT has better earnings visibility and less commodity beta; prefer the one with supply-chain scarcity pricing over the one with uranium price sensitivity.
• Initiate a small speculative long OKLO via call spreads into 2027 milestones, not common stock: upside is large if licensing stays on track, but downside is severe if timelines slip or financing costs rise.
• Take profits selectively in CCJ on strength: if uranium sentiment extends without a corresponding pickup in utility contracting, expect a high-beta re-rating that can fade over the next 1-2 quarters.
• Pair trade BWXT long / short a weaker industrial-capex proxy over 6-12 months if you want a cleaner nuclear infrastructure expression; BWXT should capture more of the spend because of regulatory barriers and defense demand.
• Use pullbacks to add BWXT rather than chasing OKLO: risk/reward is better because BWXT participates in both civilian and defense nuclear spending, reducing single-event dependence.